Antibodies News and Research

RSS

McMaster researchers to study why some people are more susceptible to SARS-CoV-2

Two McMaster University professors have received research funding to boost their work to identify COVID-19 infection rates and to understand why some people are more susceptible to the virus.

17 Apr 2020

Study identifies two new viruses in Brazilian patients with suspected dengue

Two new species of viruses have been identified in blood samples taken from patients in Brazil's northern region who had similar symptoms to those of dengue or Zika, such as high fever, severe headache, rash and red skin spots.

17 Apr 2020

Nasal smear as screening test for allergic rhinitis

Stuffy noses, itching and fits of sneezing - 130 million people in Europe suffer from hay fever and other forms of allergic rhinitis. Until now, these conditions have typically been diagnosed using blood samples or skin prick tests.

17 Apr 2020

Cancer immunotherapy can lead to inflammation of the heart muscle

Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of its most serious side effects.

17 Apr 2020

URMC launches new coronavirus study to examine immune response

The University of Rochester Medical Center is launching a new study to understand how the body's immune system responds to COVID-19, including if and when a person could be re-infected with the virus and whether some people have pre-existing immunity.

17 Apr 2020

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

A new study published in Chemrxiv in April 2020 describes the identification of 64 compounds that could potentially be inhibitors of replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current COVID-19 disease pandemic. The research was carried out using a pharmacophore model of an essential viral enzyme, mining data from the Food and Drug Administration (FDA) database of conformations of approved drugs.

16 Apr 2020

The benefits of breastfeeding during COVID-19 crisis

While the current coronavirus pandemic continues to affect all people, families will still give birth and bring new life into the world.

16 Apr 2020

Potential universal Ebola vaccine may neutralize all four harmful virus species

Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent outbreaks, mainly in Africa.

16 Apr 2020

Specialized proteins could soak up excess cytokines in COVID-19 patients

One of the defining features of Covid-19 is the excessive immune response that can occur in severe cases. This burst of immune overreaction, also called a cytokine storm, damages the lungs and can be fatal.

16 Apr 2020

Canadian Coalition Fosters Collaboration in Fight Against COVID-19

A group of Canadian biotech companies are joining forces in the war on COVID-19 with an open-source model using next-generation antidotes known as nanobodies1.

From SignalChem Biotech Inc. 16 Apr 2020

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

The U.S. Food and Drug Administration today announced it granted Emergency Use Authorization to Ortho Clinical Diagnostics' total antibody assay for COVID-19—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Calibrators.

From Ortho-Clinical Diagnostics, Inc. 16 Apr 2020

Screening blood samples for COVID-19 using artificial intelligence

A promising new study published in the preprint online journal medRxiv in April 2020 shows the potential of artificial intelligence (AI) for developing a patient classifier that can separate patients likely to be negative for COVID-19 from among a pool of suspected patients visiting an emergency room (ER).

15 Apr 2020

European Commission issues guidelines on coronavirus testing methodologies

Today, as part of the European Roadmap towards lifting coronavirus containment measures, the Commission is presenting guidelines on coronavirus testing methodologies.

15 Apr 2020

'Chaperone protein' protects against autoimmune diseases, mice study shows

Like a parent of teenagers at a party, Mother Nature depends on chaperones to keep one of her charges, the immune system, in line so that it doesn't mistakenly attack normal cells, tissues and organs in our bodies.

15 Apr 2020

China with the world: COVID-19 experts dialogues - the 4th talk transcript

Q (Prof. Singer): What do you think about the comorbidities and the age of the patients in the treatment of COVID-19? Is the mortality higher in elderly patients as it is reported from recent papers?

From Mindray 15 Apr 2020

Researchers decode how immune sensor plays role in defending cells against intruders

Until now, the immune sensor TLR8 has remained in the shadows of science. A research team led by the University of Bonn has now discovered how this sensor plays an important role in defending human cells against intruders.

15 Apr 2020

A desperate scramble as COVID-19 families vie for access to plasma therapy

Stephen Garcia's family is frantic. The auto body worker, just 32 years old, has been on a ventilator in a Los Angeles-area hospital for nearly two weeks, gravely ill with COVID-19, unresponsive — and unaware of the battle they're waging on his behalf.

15 Apr 2020

New blood test for antibodies in COVID-19 infected

The COVID-19 disease pandemic is raging across the world, costing tens of thousands of lives. Many countries have enforced widespread, if not universal lockdowns, to prevent the spread of the virus to new areas, carried by infected travelers.

14 Apr 2020

New vaccine for Chikungunya reported safe and well-tolerated

A virus-like particle vaccine was shown to be safe and well-tolerated among a healthy adult population living in chikungunya endemic areas, the researchers report in a new study published in the Journal of the American Medical Association (JAMA).

14 Apr 2020

Johns Hopkins experts create clinical guidebook for convalescent plasma therapy

A team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centers rapidly scale up their ability to deliver so-called convalescent plasma therapy, which leverages immune system components found in the plasma portion of blood from people who have recovered from COVID-19 illness.

14 Apr 2020